131 related articles for article (PubMed ID: 11589650)
1. Cognitive correlates of supratentorial atrophy on MRI in multiple sclerosis.
Edwards SG; Liu C; Blumhardt LD
Acta Neurol Scand; 2001 Oct; 104(4):214-23. PubMed ID: 11589650
[TBL] [Abstract][Full Text] [Related]
2. Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: Results of a 17-year longitudinal study.
Granberg T; Martola J; Bergendal G; Shams S; Damangir S; Aspelin P; Fredrikson S; Kristoffersen-Wiberg M
Mult Scler; 2015 Aug; 21(9):1151-8. PubMed ID: 25480866
[TBL] [Abstract][Full Text] [Related]
3. Subclinical MRI disease activity influences cognitive performance in MS patients.
Damasceno A; Damasceno BP; Cendes F
Mult Scler Relat Disord; 2015 Mar; 4(2):137-43. PubMed ID: 25787189
[TBL] [Abstract][Full Text] [Related]
4. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
[TBL] [Abstract][Full Text] [Related]
5. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
[TBL] [Abstract][Full Text] [Related]
6. Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease.
Goldman JG; Bledsoe IO; Merkitch D; Dinh V; Bernard B; Stebbins GT
Neurology; 2017 Mar; 88(13):1265-1272. PubMed ID: 28235816
[TBL] [Abstract][Full Text] [Related]
7. MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index.
Granberg T; Bergendal G; Shams S; Aspelin P; Kristoffersen-Wiberg M; Fredrikson S; Martola J
J Neuroimaging; 2015; 25(6):996-1001. PubMed ID: 25786805
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging correlates of dementia in multiple sclerosis.
Huber SJ; Paulson GW; Shuttleworth EC; Chakeres D; Clapp LE; Pakalnis A; Weiss K; Rammohan K
Arch Neurol; 1987 Jul; 44(7):732-6. PubMed ID: 3593063
[TBL] [Abstract][Full Text] [Related]
9. The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
Yaldizli Ö; Penner IK; Frontzek K; Naegelin Y; Amann M; Papadopoulou A; Sprenger T; Kuhle J; Calabrese P; Radü EW; Kappos L; Gass A
Mult Scler; 2014 Mar; 20(3):356-64. PubMed ID: 23959709
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings.
Piras MR; Magnano I; Canu ED; Paulus KS; Satta WM; Soddu A; Conti M; Achene A; Solinas G; Aiello I
J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):878-85. PubMed ID: 12810771
[TBL] [Abstract][Full Text] [Related]
11. The effect of morphological and microstructural integrity of the corpus callosum on cognition, fatigue and depression in mildly disabled MS patients.
Van Schependom J; Gielen J; Laton J; Sotiropoulos G; Vanbinst AM; De Mey J; Smeets D; Nagels G
Magn Reson Imaging; 2017 Jul; 40():109-114. PubMed ID: 28438714
[TBL] [Abstract][Full Text] [Related]
12. MRI correlates of cognitive impairment in childhood-onset multiple sclerosis.
Till C; Ghassemi R; Aubert-Broche B; Kerbrat A; Collins DL; Narayanan S; Arnold DL; Desrocher M; Sled JG; Banwell BL
Neuropsychology; 2011 May; 25(3):319-32. PubMed ID: 21534686
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis.
Pinter D; Khalil M; Pichler A; Langkammer C; Ropele S; Marschik PB; Fuchs S; Fazekas F; Enzinger C
Neuroimage Clin; 2015; 7():715-20. PubMed ID: 25844323
[TBL] [Abstract][Full Text] [Related]
14. Thalamic atrophy and cognition in multiple sclerosis.
Houtchens MK; Benedict RH; Killiany R; Sharma J; Jaisani Z; Singh B; Weinstock-Guttman B; Guttmann CR; Bakshi R
Neurology; 2007 Sep; 69(12):1213-23. PubMed ID: 17875909
[TBL] [Abstract][Full Text] [Related]
15. 'Importance sampling' in MS: use of diffusion tensor tractography to quantify pathology related to specific impairment.
Lin X; Tench CR; Morgan PS; Niepel G; Constantinescu CS
J Neurol Sci; 2005 Oct; 237(1-2):13-9. PubMed ID: 16109428
[TBL] [Abstract][Full Text] [Related]
16. [Disseminated sclerosis: organic basis for mental disorders and cognitive dysfunction].
Stenager E; Knudsen L; Jensen K
Nord Med; 1991; 106(2):43-4, 49. PubMed ID: 2006091
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients.
Benedict RH; Hulst HE; Bergsland N; Schoonheim MM; Dwyer MG; Weinstock-Guttman B; Geurts JJ; Zivadinov R
Mult Scler; 2013 Oct; 19(11):1478-84. PubMed ID: 23459570
[TBL] [Abstract][Full Text] [Related]
18. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
19. [Brain atrophy and cognitive disorder in multiple sclerosis].
Pál E; Kosztolányi P; Perlaky P
Orv Hetil; 2002 Dec; 143(48):2681-5. PubMed ID: 12501577
[TBL] [Abstract][Full Text] [Related]
20. Cognitive and brain imaging measures of multiple sclerosis.
Pozzilli C; Passafiume D; Anzini A; Borsellino G; Koudriavsteva T; Sarlo G; Fieschi C
Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):133-6. PubMed ID: 1345734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
